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A B S T R A C T
Gait analysis is recognized as a useful assessment tool in the ﬁeld of human movement research. However,
doubts remain on its real eﬀectiveness as a clinical tool, i.e. on its capability to change the diagnostic-therapeutic
practice. In particular, the conditions in which evidence of a favorable cost-beneﬁt ratio is found and the
methodology for properly conducting and interpreting the exam are not identiﬁed clearly.
To provide guidelines for the use of Gait Analysis in the context of rehabilitation medicine, SIAMOC (the
Italian Society of Clinical Movement Analysis) promoted a National Consensus Conference which was held in
Bologna on September 14th, 2013. The resulting recommendations were the result of a three-stage process
entailing i) the preparation of working documents on speciﬁc open issues, ii) the holding of the consensus
meeting, and iii) the drafting of consensus statements by an external Jury. The statements were formulated based
on scientiﬁc evidence or experts’ opinion, when the quality/quantity of the relevant literature was deemed
insuﬃcient.
The aim of this work is to disseminate the consensus statements. These are divided into 13 questions grouped
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in three areas of interest: 1) General requirements and management, 2) Methodological and instrumental issues,
and 3) Scientiﬁc evidence and clinical appropriateness.
SIAMOC hopes that this document will contribute to improve clinical practice and help promoting further
research in the ﬁeld.
1. Introduction
Gait Analysis (GA) is recognized as a useful assessment tool in the
ﬁeld of human movement research. However, doubts remain on its real
eﬀectiveness as a clinical tool, i.e. on its capability to change the di-
agnostic-therapeutic practice. In particular, the conditions in which
evidence of a favorable cost-beneﬁt ratio exists, and the methodology
for properly conducting and interpreting results, are not clearly de-
ﬁned. With the aim of providing guidelines for the use of GA in the
context of clinical medicine, SIAMOC (Italian Society of Clinical
Movement Analysis) promoted a National Consensus Conference which
was held in Bologna, Italy, on September 14th, 2013. The purpose of
the conference was to produce evidence-based recommendations to
assist a) practitioners in managing gait examination and interpreting its
results, and b) administrators in deﬁning appropriateness and re-
muneration.
Recommendations should stem from scientiﬁc evidence. If the
quality/quantity of knowledge is not deemed as suﬃcient, it is justiﬁ-
able to appeal to a process of consensus, by integrating the opinion of
experts with the available literature, following the procedure deﬁned
by established guidelines. For Italy, an oﬃcial National Guidelines
System is available (http://www.snlg-iss.it/home_en#) and used for
reference.
For the Consensus Conference, three areas of interest were con-
sidered as a priority: 1) General requirements and management, 2)
Methodological and instrumental issues, and 3) Scientiﬁc evidence and
clinical appropriateness. Three working groups were then set up and
asked to answer a total of 13 questions through preparatory documents.
These were publicly discussed in front of a multi-professional Jury. The
Jury independently evaluated the quality of the sources and the
methodology applied by the working groups.
The following sections summarize the process that led to the iden-
tiﬁcation of the Consensus topics, the deﬁnition and set-up of the
working groups, and the formulation of the ﬁnal consensus statements
for each question.
2. Methods
2.1. Identiﬁcation of the topics for the consensus
To deﬁne the topics of interest for the Consensus Conference,
SIAMOC appointed an Organizing Committee made by three senior
members (two physicians and a rehabilitation engineer). The
Organizing Committee listed 10 topics of possible interest (see Annex 1
in Supplementary material) that were sent to the SIAMOC registered
members (70 people). Each receiver had to rate the interest in each of
the topics, on a 0–10 scale, with the possibility to express comments
and suggestions. Thirty-one questionnaires (44%) were returned, whose
scores are summarized in Annex 1 in Supplementary material.
Responders had diﬀerent professional backgrounds (48% physicians,
42% engineers, 10% physiotherapists), which were representative of
the expertise in SIAMOC. Based on the answers received, three main
areas of interest were identiﬁed, each including a set of issues for a total
of 13 questions (Table 1).
2.2. Set-up of the multidisciplinary working groups
For each area of interest, a separate working group was formed. To
identify the participants, SIAMOC sent out a public call among its
members asking to express the willingness to actively participate. Fifty
people accepted and, based on their responses, the Organizing
Committee set up the three groups. Eﬀorts were made to balance the
proportions among engineers, medical doctors, and physiotherapists,
also considering the speciﬁc topics of the groups. For each group, the
Organizing Committee appointed a coordinator and a supervisor from
within the Committee itself. Table 2 gives the ﬁnal composition of the
three groups.
2.3. Preparatory documents and jury conclusions
Each group was ﬁrst required to address each question through
literature search and, in case of insuﬃcient or missing evidence, by
reaching an internal agreement. Diﬀerent search strategies were
Table 1
Areas and Critical Questions that were addressed with the Consensus Conference.
Area Critical Questions
Area 1 General issues and management Question 1.1: How would you deﬁne Gait Analysis?
Question 1.2: What are the essential and accessory professional proﬁles for a Clinical Gait Analysis Laboratory?
Question 1.3: What training is required for the personnel of a Clinical Gait Analysis Laboratory?
Question 1.4: Which characteristics should a Clinical Gait Analysis Laboratory have for accreditation and which
procedures should be followed?
Question 1.5: What are the minimum health services provided by a Clinical Gait Analysis Laboratory and their costs?
Area 2. Methodological and instrumental issues Question 2.1: What is the minimum equipment needed for performing a clinical gait analysis examination?
Question 2.2: Is there an appropriate commercial instrumentation for clinical gait analysis?
Question 2.3: What are the recommended procedures to verify the quality of the measurements performed by the
equipment, once installed in the laboratory?
Question 2.4: What are the best practice guidelines for using gait analysis instrumentation with patients?
Question 2.5: Is it necessary to adopt a standard procedure for the conduction of the examination?
Area 3: Scientiﬁc evidence and clinical appropriateness Question 3.1: What are the pathologies suitable for clinical gait analysis?
Question 3.2: What are the eﬀects of gait analysis on decision making?
Question 3.3: What are the eﬀects of gait analysis on outcome?
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performed depending on the questions. Where applicable, each pub-
lished contribution was assessed in terms of quality of evidence using
the Critical Appraisal Skills Program (CASP) (http://www.casp-uk.net/
). The overall quality of each paper, deﬁned by the total CASP score
(CASPtot), was classiﬁed into four classes: poor (CASPtot lesser than
25%), mild (between 25% and 50%), good (between 50% and 75%),
excellent (greater than 75%). Annexes 2, 3 and 4 in Supplementary
material report the literature search strategies, the exclusion/inclusion
criteria for article selection, and summarizes how the consensus within
each working group was achieved. On this basis, the group ﬁnally
drafted a conclusive document that was presented to the Jury. The Jury
was formed by the experts listed in Table 3. Within the Jury, agreement
was reached by consensus after discussion of each individual question.
3. Area 1: general issues and management
3.1. Question 1.1: how would you deﬁne clinical gait analysis?
Gait Analysis is a process of instrumented measurement and eva-
luation of walking ability in patients with impairments speciﬁc to lo-
comotion [1–16] (see also Annex 2 in Supplementary material). GA
aims at answering questions subtending clinical decisions and/or
monitoring, and is part of a broader technology of instrumented ana-
lyses of human movement. GA, as intended herein, does not refer to a
generic method for recording gait parameters, but rather to the way to
answer a speciﬁc clinical question. Measurements must be related to the
individual clinical problem, with the aim of supporting medical deci-
sion-making [1]. Therefore, the term Clinical Gait Analysis (CGA) will
be used hereinafter.
3.2. Question 1.2: what are the essential and supplemental professional
proﬁles for a CGA laboratory?
The professionals working in a laboratory performing a CGA must
have: 1) knowledge of biomechanics and neurophysiology of human
movement in both physiological and pathological conditions, 2)
knowledge of advantages and limitations inherent in the diﬀerent
techniques adopted for data recording, analysis and interpretation, 3)
adequate skills in the practical execution of the assessment, and 4)
adequate preparation for data processing and representation.
Based on the above, the professional proﬁles for a CGA laboratory
are:
• Physicians, specialized in areas relevant to the study of movement
(Physiatrists, Orthopedists, Neurologists or Sports Medicine physi-
cians);
• Health care professionals with speciﬁc interest in the diseases of
human neuro-musculoskeletal system (Physiotherapists,
Psychomotor Developmental Therapists, Occupational Therapists);
• Biomedical Engineers with speciﬁc expertise on the locomotor ap-
paratus and the use of basic instruments involved in CGA;
• Human movement scientists/Kinesiologists (whose health care
competences are deﬁned by national rules).
Most patients referred to a GA laboratory carry disabilities that may
require the assistance of further healthcare personnel (e.g. nurses) to
take appropriate actions during the examination.
The presence or availability of a Biomedical Engineer with experi-
ence in GA is highly recommended to improve the functionality of the
laboratory, to ensure the continuity of the service and to support the
process of continuous innovation [5].
3.3. Question 1.3: what training is required for the personnel of a CGA
laboratory?
Instrumented GA requires the knowledge of speciﬁc procedures [1]
(see also Annex 2 in Supplementary material). Training may be ob-
tained through practice in a GA laboratory, as well as through appro-
priate educational courses. Therefore, all professionals working in a GA
laboratory must possess:
- An academic degree in inherent disciplines and, for graduates in
medicine, a proper specialization;
- Experience in a GA laboratory;
- Speciﬁc professional training certiﬁed by academic laboratories, or
achieved through courses oﬀered by recognized scientiﬁc or
healthcare institutions. Although there is an overall lack of educa-
tional programs, a dedicated Clinical Gait Analysis Postgraduate
Course was launched as part of the EU CMAster project (http://
faber.kuleuven.be/eng/projects/cmaster).
3.4. Question 1.4: what are the characteristics needed in a CGA laboratory
to obtain an accreditation and which procedures should be followed?
It is highly advisable that healthcare authorities implement formal
accreditation procedures and that GA laboratories working on patients
ﬁle for such an accreditation [22,23] (see also Annex 2 in Supple-
mentary material).
In the absence of a formal legislation, each laboratory’s adminis-
trative department should deﬁne the procedures for internal accred-
itation. These must include the deﬁnition of speciﬁc structural, tech-
nological and organizational standards that Gait Analysis laboratories
should possess. In addition, procedures ought to deﬁne the methodol-
ogies to monitor the services’ quality. Such standards have been pre-
viously provided both by the CMAS (Clinical Movement Analysis
Society) [24] and the CMLA (North American Commission for Motion
Laboratory Accreditation, Inc.) [25], which are both trustworthy and
widely recognised. According to these standards, the following points
must be addressed: 1) Laboratory policy (mission and vision), including
planned responsibilities and deﬁnition of a “product catalog”; 2)
Communication with the user and the client in general; 3) Organization
Table 2
Members of the working groups.
Working Group 1:
General issues and
management
Working Group 2:
Methodological and
instrumental issues
Working Group 3:
Scientiﬁc evidence and
clinical appropriateness
Medical doctors: 6 Medical doctors: 6 Medical doctors: 9
Engineers: 5 Engineers: 10 Engineers: 5
Physiotherapists: 3 Physiotherapists: 2 Physiotherapists: 3
Motor Scientist: 1
Table 3
Members of the Jury.
Beghi Ettore (President
of the Jury)
IRCCS Istituto di Ricerche Farmacologiche Mario
Negri, Milano
Basaglia Nino Azienda Ospedaliero-Universitaria di Ferrara, Italy
Beretta Giovanna SC Medicina Riabilitativa e Neuroriabilitazione A.O.
Ospedale Niguarda Ca' Granda, Milano
Cappozzo Aurelio Dipartimento di Scienze del Movimento Umano e
dello Sport Università degli Studi di Roma “Foro
Italico”
Cecchetto Simone Area della Riabilitazione dell'A.P.S.S. della Provincia
Autonoma di Trento
De Tanti Antonio Centro Cardinal Ferrari Fontanellato, Parma
Ferro Salvatore Servizio Presidi Ospedalieri Direzione Generale Sanità
e Politiche Sociali, RER
Galizio Enrico Studio Medico Legale Galizio-Massimelli. Torino
Macellari Velio Istituto Superiore di Sanità, Roma
Melazzini Mario Regione Lombardia, Centro Clinico Nemo, Ospedale
Niguarda, Milano
Muller Bertran INEFC and UB, Barcelona/Spain.
Zerbinati Paolo MuldiMedica Holding, Castellanza
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(accessibility, work organization, etc.); 4) Equipment (minimum pro-
vision and maintenance); 5) Basic staﬀ training, and continuing edu-
cation plan; 6) Informative systems; 7) Procedures in use; 8) Veriﬁca-
tion of results (outcome evaluation); 9) Improvement plans within the
context of a quality management system.
A CGA laboratory should serve a population large enough to collect
a sizable number of subjects presenting the sequelae of speciﬁc dis-
abling conditions, particularly for severe developmental motor im-
pairments, brain injury, stroke and cerebral palsy (CP), and amputees
(see Area 3). This ensures the possibility to achieve and retain over time
the adequate skills in speciﬁc medical conditions.
3.5. Question 1.5: what are the minimum health services provided by a CGA
laboratory and their costs?
Two levels of examination must be considered. At a ﬁrst level, the
clinical evaluation of the lower-limb impairment is combined with the
assessment of spatial-temporal parameters, kinematics and kinetics
during gait, by using a stereophotogrammetric system and force plates.
At a second level, the examination is complemented with dynamic
electromyography (EMG) during gait, through surface or ﬁne-wire
implanted electrodes.
Services shall be provided upon request of a medical specialist in
Physical and Rehabilitation Medicine, Neurology, Orthopedics, or Child
Neurology. If one of the clinical question is unclear, the sender should
be enquired. Results of the CGA should be incorporated in a document
describing the details of the measurements, signiﬁcant deviations from
the reference population, together with a thorough and speciﬁc re-
sponse to the clinical question. The response should not provide speciﬁc
therapeutic indications.
At present, no reference documentation is available concerning the
costs for the services provided by a CGA laboratory. Cost and cost ef-
fectiveness analysis studies should be promoted taking into account
procedures, equipment, consumables, staﬀ costs (including reporting
and product delivery to the sender), and overhead costs.
4. Area 2. Methodological and instrumental issues
4.1. Question 2.1: what is the minimum equipment needed for performing a
CGA examination?
By reviewing the equipment available in all SIAMOC Gait
Laboratories (as listed on the SIAMOC website) and published reports
[1,9,18–20], it is evident that laboratories use a wide variety of in-
struments. However, given the deﬁnition of CGA and referring to
Question 1.6 it was agreed that, to date, the minimum set of measure-
ment systems are: stereophotogrammetry, force platforms and EMG.
Only these instrumentations will be considered in the remaining sec-
tions.
4.2. Question 2.2: are there commercial instrumentations available to
complete a CGA?
In this section, we will only refer to “direct measurements”, i.e.
those directly obtained from the instruments: the position of markers
for stereophotogrammetry, force and torque for force platforms, and
muscle electric potentials for electromyography.
4.2.1. Stereophotogrammetry
Several commercial stereophotogrammetric systems are available
for CGA. This conclusion is based on the analysis of the 1) sampling
frequency, and 2) spatial accuracy. Regarding the former parameter,
most systems exceed the minimum requirement of 20 Hz [27]. Re-
garding the latter, published reports [28–30] concluded that, when the
manufacturer’s guidelines are followed, errors in the reconstruction of
markers’ position have a secondary eﬀect on joint kinematics compared
to other more relevant issues such as the identiﬁcation of anatomical
landmarks and soft tissue artifacts. Since the levels of accuracy declared
by manufacturers (typically< 0.5 mm) refer to systems properly in-
stalled and calibrated, performances should be veriﬁed in situ before
each experimental session [31].
4.2.2. Force plates
Several commercial force plates are suitable for clinical GA. This
conclusion is based on the analysis of: 1) the output available from the
systems, and 2) the accuracy in static and dynamic conditions.
Regarding the ﬁrst point, systems exist that provide the 3D components
of forces and torques along with the position of the center of pressure.
Regarding the second point, a systematic review of the literature (see
Annex 3 in Supplementary material) highlighted a very limited number
of papers addressing the problem. These studies agreed that commercial
products with appropriate accuracy exist, but their performances can
decay over time. Periodic in situ calibration is therefore recommended
to reveal errors in the estimation of the position of the stereo-
photogrammetric system (i.e. of one or more cameras), with respect to
the force plates. Most platforms feature a resonance frequency higher
than 500 Hz, which is suitable for GA.
4.2.3. Electromyography
Several systems suitable for CGA are commercially available. Some
of them can be used both with surface and ﬁne-wires electrodes. These
systems can be characterized by more than twenty technical para-
meters. Focusing on the most common, based on a systematic review of
the literature [32–39] it can be concluded that systems should feature:
input impedance> 10MΩ, input noise< 1 μVRMS (corresponding to
about 4–6 μVpp) in the useful band of the signal (10–500 Hz),
CMRR>90 dB, and a sampling rate of 1 kHz or higher. Signal ﬁltering
should be high pass (10–20 Hz) and then low-pass (400Hz–450 Hz).
The A/D digital converter should be at least 12 bit. Concerning elec-
trodes, they should be of the bipolar type, with Ag/AgCl skin contact,
and with the diameter to be chosen as a function of the muscle size (but
typically comprised between 8 and 10 mm, with 1 to 2 cm interelec-
trode distance).
4.3. Question 2.3: what are the recommended procedures to verify the
quality of the measurements performed by the equipment, once installed in
the laboratory?
No data are currently available on quality control of CGA services,
despite being relevant in three phases of service provision: 1) laboratory
accreditation by an independent third party, based on objective mea-
sures of precision and accuracy of the measured and estimated vari-
ables, as well as on compliance with the good practice rules discussed in
Section 2.4; 2) periodic assessment of the quality of laboratory perfor-
mance by the laboratory staﬀ using similar procedures as per the above
point 1); and 3) preparation of reports, including notes describing the
precision and accuracy of the data provided.
4.3.1. Stereophotogrammetry
A complete review of the strategies for quality check is reported in
Chiari et al. [28]. Several methods are available to evaluate either the
random or the systematic components of the error [31] and to si-
multaneously check the stereophotogrammetric and the force platforms
systems [40]. These methods can be extremely useful to conduct rou-
tine tests for maintenance, e.g. monthly. Before each experimental
session, it is instead advised to check the correct functioning of the
system in a simpler and more immediate way. For this purpose, the full-
volume test [41] is suggested as a minimum recommended method; this
is performed moving a rod carrying two markers at known distance
inside the calibration volume. This information is often provided at the
end of system calibration by the manufacturers. It is good practice to
check the exact parameters provided by speciﬁc equipments. In case of
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doubts, it is advisable to run a test with an ad-hoc data analysis.
4.3.2. Force plates
The calibration of a force platform is usually performed by the
manufacturer, which is expected to provide a calibration sheet re-
porting the assessed accuracy and calibration matrix for each speciﬁc
device. However, the accurate calibration of a force platform is an ex-
pensive and time-consuming procedure and not all commercial devices
are accompanied by a complete calibration matrix. Moreover, calibra-
tion parameters, and thus accuracy, depend on the appropriate in-
stallation of the device (e.g. ground anchorage, mechanical isolation,
alignment and stability of the support surface) and can change with use
and time, due to aging of the components.
Relatively recent literature [40,42–50] suggests the good-practice of
in-situ assessment to test the performance of each device, and proposes
methods for in-situ calibration of the force plates that can compensate
for installation defects and/or for potential modiﬁcations due to time
and use. Such accurate in-situ assessment and calibration require spe-
cialized staﬀ and speciﬁc equipment, as this procedure usually imple-
ments multiple load measurements in diﬀerent positions over the force
plate and in diﬀerent directions, exploiting an accurate load cell
[45,47–50] as reference; it is therefore neither cheap nor straightfor-
ward to implement the procedure autonomously. On the other hand, in-
situ assessment and recalibration are not intended to be performed
frequently (i.e. they can be completed after installation and every few
years), and can be delegated to specialized third parties.
When the force platform is integrated with a stereophotogrammetric
system, each laboratory can regularly verify and monitor the perfor-
mance of the platform and its spatial registration in the laboratory re-
ference frame using spot checks [40,42]. The procedure requires little
time for completion and inexpensive hardware. Typically, a rigid bar of
known geometry is used, mounting reﬂective markers. The bar is used
to apply a concentrated load on the force plate along a line of action
visible to the stereophotogrammetric system. This good practice does
not allow the quantitative detailed assessment of platform performance,
yet it provides a timely quantitative feedback and alerts for corrective
interventions.
4.4. Question 2.4: what are the best practice guidelines for using gait
analysis instrumentation with patients?
4.4.1. Stereophotogrammetry
In the following section only protocols considered suitable to con-
duct a full gait analysis are considered. Specialized protocols not in-
cluding the full lower-limb, e.g. focusing on the foot [127] or on the
upper-limb [128] only, are not included.
Based on a systematic review conducted by the working group
(please refer to Annex 3 in Supplementary material for the complete list
of the studies selected), consensus was achieved on the following
statements:
a) there are several valid clinical protocols of motion analysis which
allow for an estimation of spatiotemporal or kinematic variables
(segmental or joint) from the position of reﬂective markers placed
on various segments of the patient’s body [129–132]; clinical ser-
vices should only use protocols with a record of publications sup-
porting their validity;
b) markers placement must be performed by personnel with speciﬁc
experience, and applying validated protocols. To improve test re-
liability, analyses on the same patients over time should be con-
ducted by the same examiner. When the same examiner cannot be
repeatedly involved, the analyst should evaluate inter-session dif-
ferences taking into considerations the intra- and inter-rater varia-
bility [29,132–135];
c) based on the predicted reliability of the method, the number of trials
for a given activity should range from 5 to 10 [136–138];
d) angles during static postures can be used as ﬁrst-order, macroscopic
indicators of a correct anatomical calibration;
e) the most reliable kinematic data are: hip ﬂexion-extension, knee
ﬂexion-extension, ankle ﬂexion-extension, ab-adduction and rota-
tion of the pelvis. Therefore, great attention must be paid to the
interpretation of results for pelvic tilt, internal-external rotation of
the hip, ab-adduction and internal-external rotation of knee and
ankle [12,131,135,139];
f) it is helpful to check for the presence of crosstalk at the angles of the
knee (ﬂexion being interpreted as abduction), that may indicate an
incorrect identiﬁcation of anatomical landmarks [140,141].
4.4.2. Electromyography
From the systematic analysis of the literature (Annex 3 in
Supplementary material) consensus was achieved on the following
points:
a) for sensors placement, skin should have no hair in excess [32,51], it
should be properly cleaned (with ethanol and acetone, among
others) and then gently abraded to ensure a good contact with the
electrode and reduce skin impedance (maximum recommended
impedance 10kΩ) [51];
b) a limited number of papers provide comprehensive guidelines about
surface electrode placement for the larger lower-limb muscles
[51–53]. Indications are not always in agreement and sometimes
diﬀerent landmarks are proposed. The most frequently cited pro-
cedure is the one from Hermens et al. [51];
c) for deep muscles, ﬁne-wire electrodes are typically used [53,54].
This is the solution of choice in all cases where, after recording the
signal, doubts remain for clinical decision making [55–57]. Due to
cross-talk from the neighboring Vasti, special attention is re-
commended in the placement of surface electrodes aiming at de-
tecting signals arising from Rectus Femoris [58–60];
d) if the EMG system is not wireless, the use of elastic bands and/or
tapes is recommended to secure cables to the skin and avoid artifacts
due to unstable contacts and/or movements of cables. It is advisable,
in any case, to visually inspect the acquired signal to recognize
motion artifacts that may be attenuated with subsequent ﬁltering;
e) electrodes should be positioned between the innervation zone and
the muscle-tendon junction as shown in [34,61,62], on minimal
crosstalk areas [52], and aligned along the direction of muscle ﬁbers
(accordingly to muscle anatomy) [34];
f) inter-electrode distance should be equal to or less than 20 mm [51].
When bipolar sensors are applied on small muscles, the distance
should not exceed ¼ of the length of the muscle ﬁbers;
g) crosstalk is a signal distortion due to the superimposition of signals
from multiple neighboring muscles placed beneath the measured
area [56,63,64]. Crosstalk can sometimes be reduced by minimizing
the interelectrode distance [34,60,61,64]. Minimal crosstalk areas
for electrode placement have been described in [52,53]. In general,
crosstalk removal remains an unsolved issue [60,64];
h) electrodes can move relative to the skin and cause signal noise that
can be limited through a high-pass ﬁlter, although more sophisti-
cated techniques are also available [65];
i) the assessment of the raw EMG signal does not provide reliable
conclusions independently from the assessor. Several parameters
extracted from the raw EMG signal [34,64,66–69] are available,
including:
• root-mean square (RMS) or average rectiﬁed value-ARV as in-
dicators of signal amplitude [34];
• rectiﬁed full wave EMG signal [34];
• envelope, as the result of low-pass ﬁltering the full-wave rectiﬁed
signal [34,64]. With respect to gait at spontaneous cadence, the
cutoﬀ frequency appears to be 9 Hz [34,64]. Descriptors can be
calculated from the envelope [34,64,67]; the exact type of ﬁlter,
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order and cut-oﬀ frequency should be declared in the clinical report;
• on/oﬀ detection: estimation of the time intervals in which the
muscle is active (on) and inactive (oﬀ) with respect to resting values
[66,69–71].
4.5. Question 2.5: is it necessary to adopt a standard procedure for CGA?
Consensus was achieved on the absence of a standard procedure for
the execution of CGA, which can explain the diﬀerences observed be-
tween the results provided by diﬀerent laboratories. A standard pro-
cedure must consider the following aspects: 1) reconstruction of ske-
letal movement during gait, 2) estimation of inertial parameters of body
segments, 3) measurement of external forces, 4) timing and amplitude
of muscle recruitment, 5) use of metrics for the description of gait
mechanics (i.e. the conventions for the representation of the articular
kinematics and dynamics). The understanding of gait in normal subjects
and patients would beneﬁt from the availability of public databases.
The following sections describe further consensus points that might
facilitate the deﬁnition of such standard procedure.
4.5.1. Reconstruction of skeletal movement during gait
Five review papers [12,28,29,72,73] have been published that
provide a comprehensive review about a) bone pose estimation, b) the
extraction of quantitative kinematic and kinetic variables from stereo-
photogrammetry and force platforms, and c) the eﬀect of soft tissue
artifact.
Consensus exists on the use of Anatomical Coordinate Systems cal-
culated through “anatomic calibrations”, based on the coordinates of at
least three anatomical landmarks. In some cases, functionally deﬁned
centers and/or axes of rotation can be used as well. This approach is
viable when there is a constant and generalizable relationship between
anatomy and function among individuals, such as for the hip center of
rotation [74,142].
4.5.2. The estimation of inertial parameters of body segments
Estimations of inertial parameters for each body segment is made
possible by adopting anthropometric models and regression equations
[75–81]. Given the small accelerations typical of gait, consensus was
achieved on the limited eﬀect of the uncertainty in body segment
parameters estimation during gait dynamics assessment. However,
some attention must be paid to the prosthetic leg of amputees during
the swing phase, as a direct measure of the inertial parameters of the
prosthesis may be required in this case [82].
4.5.3. The metric for the description of gait mechanics
CGA should assess if the patient fulﬁlls three fundamental aspects of
gait, namely: 1) physical exertion, 2) maintenance of balance, and 3)
preservation of the structures of the musculoskeletal system. Consensus
was reached on the absence of CGA variables that can summarize all
these determinants. It is therefore recommended to support research
eﬀorts aimed at deﬁning such a metric [83].
4.5.4. Normative data
Normative data should be available [143] for the interpretation of
CGA results of a given subject. According to the literature [84] nor-
mative values based on mean and standard deviation, for every phase of
gait, lead to an underestimation of the actual intra-session and inter-
subject variability. This stems from the assumption of a normal dis-
tribution of data and from considering the points of a curve as un-
related. The literature supports the adoption of modern statistical
techniques, such as Bootstrap, that allow to overcome these methodo-
logical pitfalls [84,85].
4.5.5. Reference population
It was agreed that when the goal of the analysis is the assessment of
functional limitations, the reference population for a patient should
comprise asymptomatic subjects with the same sex and belonging to the
same age range (e.g. childhood, adult, or elderly). It is therefore ne-
cessary to give the operators normative data following the same logic
[86]. It should also be possible to compare data collated on persons
with diﬀerent anthropometric characteristics [144,145]. While it might
be plausible to have separate normative data for people with normal
weight and obese, within each of these categories normalization by
body mass and stature appears suﬃcient.
4.5.6. Pace (step cadence)
Gait can be achieved using diﬀerent paces. The most obvious dis-
tinction is given by the speed of progression. Therefore, normative data
must be provided for speed classes. It should also be noted that an in-
dividual’s rate of progression correlates with the height. It follows that
also the speed parameters should be subjected to normalization
[85,86,144]. Of course, care should be taken in treating the EMG vs
speed correlation, as reported in [146,147].
5. Area 3: scientiﬁc evidence and clinical appropriateness
5.1. Question 3.1: what are the clinical conditions suitable for clinical gait
analysis?
Despite the large number of studies in which GA was performed,
cerebral palsy, acquired lesions of the central nervous system (stroke,
degenerative diseases, trauma) and prostheses in lower limb amputa-
tions are the only clinical conditions for which published literature of
suﬃcient quality is available to support the use of CGA as a diagnostic
or prognostic tool [1,9,15,16,87–126] (see also Annex 4 in Supple-
mentary material). Moreover, with the exception of cerebral palsy (CP),
the published observations relate to isolated cases or to a very limited
number of patients.
5.2. Question 3.2: what are the eﬀects of gait analysis on decision making?
Following a careful evaluation of the available literature, the fol-
lowing statements have been agreed upon:
1. In cerebral palsy, the use of GA combined with an expert clinical
evaluation can inﬂuence the planning of functional surgery, leading
to modiﬁcation of the clinical decision in case of disagreement or
reinforcing the decision in the event of agreement (class I, level of
evidence B)[16,86–91,94,95,97–99,101–106].
2. In adult brain injuries, the use of GA combined with an expert clinical
evaluation can inﬂuence the planning of functional orthopedic
surgery, neuromuscular blocks and/or rehabilitation programs (class
I, level of evidence C) [93,96].
3. In patients wearing prostheses after lower limb amputations the clinical
utility of GA, albeit reasonable, still remains to be proven (class III,
level of evidence C); however, this does not preclude its use for sci-
entiﬁc research, for choices regarding the construction of the pros-
thesis and for the planning of general models of rehabilitation
[88,100].
5.3. Question 3.3: what are the eﬀects of CGA on outcome?
The eﬃcacy of CGA on two speciﬁc aspects of outcome assessment
have been analyzed:
The individual clinical outcome, intended as the impact of CGA on
treatment decisions and, indirectly, on the evolution of the deﬁcit
[16,90,91,97,99,101–103];
The social outcome made by the consumption of health care re-
sources [111].
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5.3.1. Individual clinical outcome
1. In children with CP the use of CGA combined with an expert clinical
assessment is capable to favorably inﬂuence the outcome of func-
tional surgery (class I, level of evidence B).
2. In children with CP there is no suﬃcient evidence that the use of CGA
combined with expert clinical evaluation may improve the outcome
of patients undergoing non-surgical treatments (neuromuscular
blocks, rehabilitation programs) (class IIb, level of evidence C).
3. In adult patients with acquired brain injuries there is no suﬃcient
evidence that the use of GA combined with expert clinical evalua-
tion can improve the outcome of patients undergoing functional
surgery (class IIb, level of evidence C).
5.4. Consumption of health care resources
The use of GA can result in savings of resources for the health care of
CP. No conclusion can be drawn about the other clinical conditions
examined (class IIa, level of evidence C).
6. Recommendation for future research
The lack of adequate scientiﬁc documentation for the correct use of
GA in clinical practice stands in contrast with its high potential as a tool
for scientiﬁc research. Therefore, the Jury formulated several re-
commendations for future research. These are summarized in Table 4.
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